IBREXAFUNGERP CITRATE
UNII M4NU2SDX3E

Substance Identification & Data

This profile provides standardized clinical and technical data for Ibrexafungerp Citrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) M4NU2SDX3E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1965291-08-0 and the RxNorm Concept ID (RxCUI) 2560215. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

M4NU2SDX3E

CAS Registry Number

1965291-08-0

RxNorm Concept ID

2560215

Detailed Substance Profile

Preferred Name

IBREXAFUNGERP CITRATE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

M4NU2SDX3E

The specific atomic composition represented as a molecular structure string.

InChIKey

C44H67N5O4.C6H8O7

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WKIRTJACGBEXBZ-FQGZCCSZSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C174692

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

137552087

Unique identification number in the NCBI database of chemical substances.

USAN ID

GH-41

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(CC(O)=O)(CC(O)=O)(C(O)=O)O.C[C@@]12[C@]3([C@@](C=4[C@](CC3)([C@]5(C)[C@](CC4)(C)[C@H](C(O)=O)[C@](CC5)([C@@H](C(C)C)C)C)[H])(C[C@H]([C@@H]1OC[C@](C(C)(C)C)(C)N)n6c(ncn6)-c7ccncc7)COC2)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ibrexafungerp Citrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IBREXAFUNGERP CITRATE

Common Names & Synonyms

IBREXAFUNGERP CITRATE [ORANGE BOOK]

IBREXAFUNGERP CITRATE [USAN]

IBREXAFUNGERP CITRATE [WHO-DD]

Brand / Trade Names

BREXAFEMME

Systematic Nomenclature

(1S,4AR,6AS,7R,8R,10AR,10BR,12AR,14R,15R)-15-((2R)- 2-AMINO-2,3,3-TRIMETHYLBUTOXY)-1,6A,8,10A-TETRAMETHYL-8- ((2R)-3-METHYLBUTAN-2-YL)-14-(5-(PYRIDIN-4-YL)-1H-1,2,4- TRIAZOL-1-YL)-1,6,6A,7,8,9,10,10A,10B,11,12,12A-DODECAHYDRO-2H,4H-1,4A-PROPANOPHENANTHRO(1,2-C)PYRAN-7-CARBOXYLIC ACID COMPOUND WITH 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID (1:1)

SYS

4H-1,4A-PROPANO-2H-PHENANTHRO(1,2-C)PYRAN-7-CARBOXYLIC ACID, 15-((2R)-2-AMINO-2,3,3-TRIMETHYLBUTOXY)-8-((1R)-1,2-DIMETHYLPROPYL)-1,6,6A,7,8,9,10,10A,10B,11,12,12A-DODECAHYDRO-1,6A,8,10A-TETRAMETHYL-14-(5-(4-PYRIDINYL)-1H-1,2,4-TRIAZOL-1-YL)-, (1S,4AR,6AS,7R,8R,10AR,10BR,12AR,14R,15R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)

SYS